Skip to main content
OpenTrials

Clinical trial condition

Mitochondrial Diseases

Explore clinical trials studying Mitochondrial Diseases. Study availability and eligibility vary by location and protocol.

226 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

Mitochondrial Diseases trial results

Completed

The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV

NCT00001034

Conditions
Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, Blood-Borne Infections, +32 more
Locations
  • Community Consortium of San Francisco San Francisco, California, United States
  • Denver CPCRA / Denver Public Hlth Denver, Colorado, United States
  • Wilmington Hosp / Med Ctr of Delaware Wilmington, Delaware, United States
  • Veterans Administration Med Ctr / Regional AIDS Program Washington D.C., District of Columbia, United States
View all 17 locations
View Trial Details
Completed

A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease

NCT00000805

Conditions
Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, Blood-Borne Infections, +24 more
Locations
  • Childrens Hosp. LA - Dept. of Ped., Div. of Clinical Immunology & Allergy Los Angeles, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
  • Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. Oakland, California, United States
View all 19 locations
View Trial Details
Completed

A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure

NCT00000691

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, +32 more
Locations
  • USC CRS Los Angeles, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
  • Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States
View Trial Details
Completed

A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir

NCT00000668

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, +32 more
Locations
  • Univ of California / San Diego Treatment Ctr San Diego, California, United States
  • San Francisco AIDS Clinic / San Francisco Gen Hosp San Francisco, California, United States
  • Davies Med Ctr San Francisco, California, United States
  • Mount Zion Med Ctr San Francisco, California, United States
View Trial Details
Completed

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

NCT00006145

Conditions
Amino Acid Metabolism, Inborn Errors, Blood-Borne Infections, Communicable Diseases, +28 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
View all 57 locations
View Trial Details
Completed

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

NCT00001061

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, +32 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • Santa Clara Valley Med. Ctr. San Jose, California, United States
  • Stanford CRS Stanford, California, United States
View all 20 locations
View Trial Details
Completed

CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")

NCT01552369

Conditions
Amino Acid Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytomegalovirus Infection, +11 more
Locations
  • Ronald Reagan University of California Los Angeles Medical Center Los Angeles, California, United States
  • Emory Clinic - Transplant Center Atlanta, Georgia, United States
  • Mayo Clinic, Rochester - Infectious Diseases Rochester, Minnesota, United States
  • Mount Sinai School of Medicine - Medicine - Infectious Diseases New York, United States
View Trial Details
Completed

Post Authorisation Safety Study With Raxone in LHON Patients

NCT02771379

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Eye Diseases, +13 more
Locations
  • Universitaetsklinikum Graz Graz, Austria
  • Medical University of Vienna Vienna, Austria
  • CHU de Nîmes - Hôpital Carémeau Nîmes, Gard, France
  • CHU Angers - Hôpital Hôtel Dieu Angers, Maine Et Loire, France
View all 26 locations
View Trial Details

Related conditions